Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Caplacizumab + Immunosuppression for Thrombotic Thrombocytopenic Purpura
Recruiting2 awardsPhase 3
Dallas, Texas
This trial will test a drug and therapy to treat a rare blood disorder in men and women aged 18-80. Treatment duration is up to 24 weeks with daily assessments during hospitalization and weekly visits for assessments during ongoing treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.